Progress, opportunities, and challenges of troponin analysis in the early diagnosis of cardiovascular diseases

X Du, X Su, W Zhang, S Yi, G Zhang, S Jiang… - Analytical …, 2021 - ACS Publications
Cardiovascular diseases (CVD) have one of the leading mortalities throughout the world; an
estimated 17.9 million people died from CVD in 2019, representing 32% of all global deaths …

Electroanalytical point-of-care detection of gold standard and emerging cardiac biomarkers for stratification and monitoring in intensive care medicine-a review

RD Crapnell, NC Dempsey, E Sigley, A Tridente… - Microchimica Acta, 2022 - Springer
Determination of specific cardiac biomarkers (CBs) during the diagnosis and management
of adverse cardiovascular events such as acute myocardial infarction (AMI) has become …

Enhancing Curcumin's therapeutic potential in cancer treatment through ultrasound mediated liposomal delivery

R Radha, V Paul, S Anjum, A Bouakaz, WG Pitt… - Scientific Reports, 2024 - nature.com
Improving the efficacy of chemotherapy remains a key challenge in cancer treatment,
considering the low bioavailability, high cytotoxicity, and undesirable side effects of some …

“Turn-on” fluorescence sensing of cardiac troponin I based on MnO2 nanosheet quenched mercaptopropionic acid capped Mn2+ doped zinc sulphide quantum dots

S Varghese, AS Madanan, MK Abraham, AI Shkhair… - Microchemical …, 2023 - Elsevier
Abstract Acute Myocardial Infarction (AMI) is the persisting serious threat among all
cardiovascular diseases due to its highest mortality rates. Clinicians resort to biomarker …

[HTML][HTML] Overview on the development of alkaline-phosphatase-linked optical immunoassays

L Liu, Y Chang, J Lou, S Zhang, X Yi - Molecules, 2023 - mdpi.com
The drive to achieve ultrasensitive target detection with exceptional efficiency and accuracy
requires the advancement of immunoassays. Optical immunoassays have demonstrated …

Multiplex label-free kinetic characterization of antibodies for rapid sensitive cardiac troponin I detection based on functionalized magnetic nanotags

AV Orlov, JA Malkerov, DO Novichikhin… - International Journal of …, 2022 - mdpi.com
Express and highly sensitive immunoassays for the quantitative registration of cardiac
troponin I (cTnI) are in high demand for early point-of-care differential diagnosis of acute …

Aptamer-modified magnetic SERS substrate for label-based determination of cardiac troponin I

C Lin, L Li, J Feng, Y Zhang, X Lin, H Guo, R Li - Microchimica Acta, 2022 - Springer
A sensitive label-based SERS strategy composed of magnetic bimetallic nanoparticles Fe 3
O 4@ Ag@ Au, specific aptamer, and Bradford method was developed for the quantitative …

Rapid Antigen Diagnostics as Frontline Testing in the COVID‐19 Pandemic

J Xu, L Kerr, Y Jiang, W Suo, L Zhang, T Lao… - Small …, 2022 - Wiley Online Library
The ongoing global COVID‐19 pandemic, caused by the SARS‐CoV‐2 virus, has resulted in
significant loss of life since December 2019. Timely and precise virus detection has been …

[HTML][HTML] Circulating forms of cardiac troponin: a review with implications for clinical practice

EJS Denessen, SIJ Nass, O Bekers… - … of Laboratory and …, 2023 - jlpm.amegroups.org
Cardiac troponin I (cTnI) and T (cTnT) became the gold-standard biomarkers for diagnosing
myocardial infarction (MI) due to their cardiac-specific amino acid sequence. Currently, both …

Methods for detecting of cardiac troponin I biomarkers for myocardial infarction using biosensors: a narrative review of recent research

Q Chen, W Wu, K Wang, Z Han… - Journal of Thoracic …, 2023 - pmc.ncbi.nlm.nih.gov
Background and Objective In cardiovascular diseases (CVDs), acute myocardial infarction
(AMI) is considered one of the leading causes of human death, and its diagnosis mainly …